Avenqor™ Nutrition UC-II® Joint
Couldn't load pickup availability
Avenqor™ Nutrition UC-II® Joint
JOINT HEALTH · CARTILAGE SUPPORT · MOBILITY
Move with confidence. Start with patented UC-II®.A daily walk. A flight of stairs. The activities you want to keep enjoying. Avenqor™ Nutrition UC-II® Joint puts patented UC-II® undenatured type II collagen at the centre of a convenient daily joint-care routine.
Each tablet delivers 40 mg of UC-II® chicken collagen blended powder—the daily ingredient amount used in the clinical studies below—alongside milk calcium powder, Euglena gracilis powder, sodium hyaluronate and turmeric extract.
One tablet a day. 60 tablets per bottle. A 60-day supply, made in New Zealand from globally sourced ingredients. No artificial colours or flavours.
Patented UC-II® — the science at the centre
UC-II® is a branded, chicken-derived ingredient containing undenatured type II collagen. Its manufacturing process preserves the native collagen structure, a key feature that distinguishes it from hydrolysed collagen. Each tablet supplies 40 mg of UC-II® blended powder, equivalent to 12.04 mg of collagen; these are different measurements, not two separate doses.
The proposed mechanism involves oral tolerance: interaction with immune tissue in the gut may help regulate immune responses to type II collagen. This explanation is supported mainly by preclinical evidence; human symptom improvements do not establish cartilage regrowth. Lonza lists UC-II®-related patents including US 11,793,217 (manufacturing) and US 9,066,926 (use). These concern the ingredient technology, rather than an Avenqor-owned patent. [1] [3]
HUMAN CLINICAL RESEARCH
Joint comfort & function | 191 participants191 participants · 180 days. A randomised, double-blind trial in adults with knee osteoarthritis compared UC-II® 40 mg/day with placebo and glucosamine hydrochloride 1,500 mg + chondroitin sulphate 1,200 mg/day. At day 180, total WOMAC scores, which assess pain, stiffness and physical function, improved more with UC-II® in the ANCOVA analysis (p = 0.002 vs placebo; p = 0.04 vs the combination). Superiority to the combination was not significant with the other reported analysis methods. [1]
PubMed RCT | Knee osteoarthritisHUMAN CLINICAL RESEARCH
Movement & flexibility | 55 participants55 participants · 120 days. In a randomised, double-blind trial of healthy adults with exercise-related knee discomfort, UC-II® 40 mg/day produced greater measured knee extension than placebo at day 120: 81.0° vs 74.0° (p = 0.011; completer analysis). [2]
p = 0.011
Both trials used 40 mg/day of UC-II®. One Avenqor tablet supplies 40 mg of UC-II® blended powder, equivalent to 12.04 mg of collagen. The blend amount is not the amount of pure undenatured collagen.
Evidence context: These ingredient studies were sponsored by InterHealth and did not test the finished Avenqor formula. Matching the studied ingredient amount does not establish identical outcomes. Results vary and do not prove cartilage repair or disease prevention.
Milk Calcium Powder
50 mg of milk calcium powder provides 13 mg of calcium per tablet, adding a milk-derived mineral component to the formula.
Calcium is required for normal bone structure, muscle function and nerve signalling. This formula provides 13 mg per tablet: a small contribution to daily intake, rather than a high-dose calcium supplement. [4]
Euglena gracilis Powder
Each tablet includes 50 mg of Euglena gracilis powder, providing 25 mg of β-glucan.
A microalgal addition to the five-ingredient blend. Its β-glucan content is clearly declared: 25 mg is already contained within the 50 mg powder.
Sodium Hyaluronate
1.5 mg of sodium hyaluronate per tablet complements the collagen-centred ingredient selection.
The sodium salt of hyaluronic acid, selected as a complementary ingredient alongside UC-II®.
Turmeric Extract
10 mg of turmeric extract brings a botanical component to the five-ingredient formula.
A turmeric-derived botanical addition. The 10 mg refers to extract; a standardised curcumin percentage is not declared.
A clear focus. Five selected ingredients. One daily tablet.
Patented UC-II® is the clinical core. Milk calcium, Euglena powder, sodium hyaluronate and turmeric extract complete the formula. Its strongest human evidence comes from UC-II®; the other ingredients should not be assumed to have proven joint benefits at the amounts provided.
40 mg UC-II® · Once daily · Made in New Zealand
Who It’s For
- Adults who want to keep walking, climbing stairs and enjoying everyday movement.
- Active adults seeking a daily routine built around a clinically studied joint ingredient.
- People who prefer patented UC-II® in a simple, once-daily tablet.
Active Ingredients per Tablet
| Ingredient | Amount |
|---|---|
| UC-II® Chicken Collagen Blended Powder | 40 mg |
| Equivalent to collagen | 12.04 mg |
| Milk Calcium Powder | 50 mg |
| Equivalent to calcium | 13 mg |
| Euglena gracilis Powder | 50 mg |
| Equivalent to β-glucan | 25 mg |
| Sodium Hyaluronate | 1.5 mg |
| Turmeric Extract | 10 mg |
Other ingredients: Tableting aids.
Contains: Milk. UC-II® is chicken-derived.
Directions
Take 1 tablet daily, or as directed by your healthcare professional.
Warnings
- Keep out of reach of children.
- Consult a healthcare professional if pregnant.
- Use with a balanced diet and exercise.
- Always use as directed. Not intended to cure or prevent any disease.
Storage
Store in a cool, dry place. Keep sealed and avoid direct sunlight. Use by the expiry date.
About the KInD™ Program
The KInD™ (Keto Intermittent Nutrigenomics Dietary) Program explores dietary approaches involving ketogenic metabolism, meal timing and nutrigenomics. Nutritional needs differ between individuals. UC-II® Joint can be taken as directed without following a ketogenic diet; its clinical evidence does not establish benefits for ketosis, weight loss or blood-glucose control.
Clinical references & patent information
[1] Lugo JP, Saiyed ZM, Lane NE. Nutrition Journal. 2016;15:14. doi:10.1186/s12937-016-0130-8.
[2] Lugo JP et al. Journal of the International Society of Sports Nutrition. 2013;10:48. doi:10.1186/1550-2783-10-48.
[3] Lonza: Intellectual Property — UC-II®-related manufacturing and use patents.
[4] NIH Office of Dietary Supplements. Calcium — Health Professional Fact Sheet.
UC-II® is a registered trademark of Lonza or its affiliates. Patent scope and protection depend on the territory and the relevant claims.
Lonza | Patent informationIngredient images are AI-generated illustrations.
